KLOW
Our most complete blend. Combines the copper tripeptide GHK-Cu, the anti-inflammatory tripeptide KPV, BPC-157 and Thymosin Beta-4 fragment TB-500, four compounds studied in skin, gut and soft-tissue repair research.
GHK-Cu (copper tripeptide-1) is a naturally occurring copper-binding peptide, supplied in a 2 mL vial.
GHK (glycyl-L-histidyl-L-lysine) was first isolated from human plasma in the early 1970s. It binds copper ions with high affinity, forming the GHK-Cu complex. Plasma levels of GHK are reported to decline with age.
GHK-Cu is one of the most studied peptides in skin-care research, where it has been investigated for its effects on collagen production, skin remodeling and wound healing.
GHK-Cu is also one of the four peptides in our KLOW blend.
A copper-binding tripeptide (glycyl-histidyl-lysine) first found in human plasma.
Yes. GHK-Cu is one of the four peptides in KLOW.
Every order ships within the US for a flat $9.
Yes. Contact us with your order details and we'll send the report for the lot you received.
Our most complete blend. Combines the copper tripeptide GHK-Cu, the anti-inflammatory tripeptide KPV, BPC-157 and Thymosin Beta-4 fragment TB-500, four compounds studied in skin, gut and soft-tissue repair research.
The classic recovery pairing. BPC-157 is a gastric-protein fragment studied in tendon, ligament and gut models; TB-500 is an actin-binding Thymosin Beta-4 fragment studied for cell migration and wound healing.
A synthetic tetrapeptide based on the pineal extract epithalamin, studied for effects on telomerase and circadian rhythm.